ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02804763
Brief Title: A Phase 2 Efficacy and Safety Study of Dapirolizumab Pegol (DZP) in Systemic Lupus Erythematosus

First Submitted : June 14, 2016
First Submitted that Met QC Criteria : June 14, 2016
First Posted : June 17, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : June 18, 2018
Last Update Posted : June 19, 2018